Search
for
Sort by
Research 421–450 of 1000+
- Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know
- Epidemiology of skin cancer in the mature patient
- There is no clear association between low serum ferritin and chronic diffuse telogen hair loss
- Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone
- Gene-wide association study between the aromatase gene (<i>CYP19A1</i>) and female pattern hair loss
- Androgenetic alopecia in men and women
- Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- Hair colouring, permanent styling and hair structure
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Permanent alopecia following chemotherapy and bone marrow transplantation
- Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
- Drugs and Hair Loss
- Chronic telogen effluvium: A study of 5 patients over 7 years
- A review of the treatment of male pattern hair loss
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial
- Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
- Finasteride for female androgenetic alopecia
- Female pattern hair loss: current treatment concepts.
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Optimal Management of Hair Loss (Alopecia) in Children
- Primary cicatricial alopecia: diagnosis and treatment
- The Ludwig pattern of androgenetic alopecia is due to a hierarchy of androgen sensitivity within follicular units that leads to selective miniaturization and a reduction in the number of terminal hairs per follicular unit
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Systemic treatments for alopecia areata: A systematic review
- Men with Kennedy disease have a reduced risk of androgenetic alopecia
- Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study
- Chronic telogen effluvium is due to a reduction in the variance of anagen duration
- Male pattern baldness: current treatments, future prospects